Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
about
The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis modelPulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportElevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.L-carnitine preserves endothelial function in a lamb model of increased pulmonary blood flowRole of carnitine in cancer chemotherapy-induced multiple organ toxicity.Pulmonary hypertension associated with thalassemia syndromes.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia.L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.Frequency of pulmonary hypertension in asymptomatic β-thalassemia major patients and the role of physiological parameters in evaluation.Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.Asymmetric dimethylarginine levels in children with β-thalassemia and their correlations to tricuspid regurgitant jet velocity.
P2860
Q28512770-B9F3CBFB-FA03-447A-9A0E-A7C3D4ED22CCQ33165207-844A0997-75A3-43F0-9A16-5425AC7CEF9BQ35346284-CEA4B478-3F2E-4EF3-AF36-2CCDCE349A5CQ35743427-E2542913-5AC5-4C83-BB6B-6DB4B6B6E30BQ37004620-C39FF58E-625F-4816-8EF1-1AB1353791FCQ38130229-D4939347-81BD-4B1F-8706-0137EFE8297BQ38786355-76988346-8DB3-482C-9BF0-324493A7F258Q41975944-1511F265-B002-4C13-B4D6-15F6ABF040AAQ43204912-0757082C-662A-4E91-AB39-5E33F6198F56Q45800063-DB533CEA-AEBD-4D61-A992-EB4BDE2AC294Q46609458-8EAA36E0-C277-4071-BD4F-4C19E825F6DAQ46789974-F99992FA-0774-4B44-BCED-1A2211B1B8CE
P2860
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
@en
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
@nl
type
label
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
@en
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
@nl
prefLabel
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
@en
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
@nl
P2093
P2860
P1476
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy
@en
P2093
Ali Makhlouf
Amal El-Beshlawy
Ilham Youssry
Sonia El-Saidi
Yassmin Mansi
P2860
P304
P356
10.1080/08880010802244035
P577
2008-12-01T00:00:00Z